^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Caris Detect™

    Company:
    Caris Life Sci
    Related tests:

    Details

    Evidence
    News
    Caris and Everlywell are partnering to launch Caris Detect™, Caris’ forthcoming Multi-Cancer Early Detection (MCED) blood-based screening assay, through Everlywell’s platform. Caris Detect utilizes comprehensive whole genome sequencing (WGS) technology to identify multiple cancer types by analyzing molecular signals circulating in the bloodstream.
    Method:
    Whole Genome sequencing